AIDS and Behavior最新文献

{"title":"Uptake of COVID-19 Vaccination and Related Factors Among People who Inject Drugs, San Francisco, 2022.","authors":"Said Iftekhar Sadaat, Alexander Marr, Ali Mirzazadeh, Bow Suprasert, Moranda Tate, Erin Wilson, Willi McFarland","doi":"10.1007/s10461-024-04564-z","DOIUrl":"https://doi.org/10.1007/s10461-024-04564-z","url":null,"abstract":"<p><p>We assessed the uptake of COVID-19 vaccination in a community-recruited sample of people who inject drugs (PWID) in San Francisco in 2022. Overall, 72.4% (95% CI 64.6-80.3) were vaccinated for COVID-19. Independent predictors of vaccination were age 65 years and older (adjusted odds ratio [AOR] 9.7, 95% CI 2.2-28.7) and ever testing positive for COVID-19 (AOR 2.0, 95% CI 1.2-3.5). Homelessness was associated with lower COVID-19 vaccination (AOR 0.5, 95% CI 0.3-0.8). Our study underscores the urgent need for targeted interventions to address unique challenges faced by PWID in accessing COVID-19 vaccination, particularly for those experiencing homelessness and who are younger.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correlates of Using Medically-Authorized Cannabis in a Large Cohort of People Living with HIV Who Use Cannabis.","authors":"Sophie G Coelho, Jeffrey D Wardell, Abigail Kroch, Sergio Rueda","doi":"10.1007/s10461-024-04568-9","DOIUrl":"https://doi.org/10.1007/s10461-024-04568-9","url":null,"abstract":"<p><p>Many people living with HIV (PLWH) use cannabis to manage symptoms, but a large proportion do so without medical cannabis authorization and use cannabis obtained outside the medical stream. In jurisdictions where non-medical cannabis use is legal, PLWH who hold medical cannabis authorization may represent a unique subgroup; yet, research on the correlates of using medical cannabis (authorized by a healthcare provider) in the context of non-medical cannabis legalization is lacking. Thus, this study examined the cannabis- and health-related correlates of medical cannabis use among PLWH in Ontario, Canada, where non-medical cannabis is legal. PLWH (N = 868; 85.37% men, mean age 51.34 years [SD = 12.25]) who were enrolled in the Ontario HIV Treatment Network Cohort Study in 2022 and who reported past-year cannabis use completed an assessment of sociodemographic characteristics, HIV-related variables, cannabis and other substance use, and health-related quality of life. Relatively few participants (n = 122; 14.06%) reported any medical cannabis use, with most (n = 746; 85.94%) reporting exclusive use of non-medical cannabis. Logistic regression analyses showed that greater HIV symptom distress, poorer physical-health-related quality of life, more frequent cannabis use, and using smokeless forms of cannabis were each uniquely associated with increased likelihood of using medical cannabis relative to exclusively using non-medical cannabis. Results suggest that even in jurisdictions where non-medical cannabis is legal, a subset of PLWH continue to access cannabis through the medical stream, and these individuals report distinct patterns of cannabis use and poorer physical health. Findings may inform cannabis policy and clinical care for PLWH who use cannabis.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study.","authors":"Mobolanle Balogun, Lisa M Kuhns, Alani S Akanmu, Robert Garofalo, Titilope Badru, Abiodun F Adekanmbi, Akinsegun Akinbami, Oche Agbaji, Agatha N David, Olayinka Omigbodun, Marbella Cevantes, Patrick Janulis, Patricia Akintan, Olutosin Awolude, Kehinde M Kuti, Oluwajimi Sodipo, Esther Yiltok, Gbenayon J Mautin, Priscilla Ezemelue, Baiba Berzins, Babafemi Taiwo","doi":"10.1007/s10461-024-04565-y","DOIUrl":"https://doi.org/10.1007/s10461-024-04565-y","url":null,"abstract":"<p><p>Viral suppression with antiretroviral therapy (ART) is a critical component of UNAIDS objectives to end the HIV epidemic. Youth living with HIV (YLH) have worse viral suppression rates than adults. The aim of this study was to identify risk factors for viral non-suppression among YLH in Nigeria. A secondary analysis of enrollment data from the iCARE Nigeria study, collected April-October 2021 for 541 YLH comprised demographic, psychosocial, behavioral, clinical variables, and viral load quantification. Viral non-suppression was defined as viral load ≥ 200 copies/mL. Generalized linear models using Akaike information criterion for selection of indicator variables in a stepwise approach were used to determine the risk factors for viral non-suppression. The final analytic sample was 491 and the proportion of non-suppressed participants at baseline was 40%. In the final model, substance use (other than alcohol, tobacco and/or cannabis) (aOR = 3.20 [95% CI: 1.05, 10.34]), missed medication doses (aOR = 1.09 [95% CI: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aOR = 1.08 [95% CI: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. Being prescribed a first-line regimen (aOR = 0.28 [95% CI: 0.17, 0.44]), disclosure to at least one brother (aOR = 0.64 [95% CI: 0.42, 0.97]), and higher treatment outcome expectancies (e.g., taking medication will improve health) (aOR = 0.81 [95% CI: 0.66, 0.98]), were all associated with a lower likelihood of viral non-suppression. Viral non-suppression among YLH in Nigeria is associated with psychosocial and behavioral factors, including missed doses, medication barriers, treatment outcome expectancies, and disclosure, that are potential targets for intervention to achieve ART goals.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Trend in Suicide Risk Among People with HIV Before, During, and After the COVID-19 Pandemic Lockdown.","authors":"Jessica Mejía-Castrejón, Yanink Caro-Vega, Juan G Sierra-Madero, Alvaro López-Iñiguez, Brenda E Crabtree-Ramírez","doi":"10.1007/s10461-024-04548-z","DOIUrl":"https://doi.org/10.1007/s10461-024-04548-z","url":null,"abstract":"<p><p>Suicide Risk (SR) and the COVID-19 pandemic affected People with HIV (PWH) disproportionately in comparison with the general population, but little information on SR during and after the COVID-19 lockdown on the Latino PWH has been described, therefore, this study aimed to describe SR in PWH attended the HIV clinic before (2018-2019), during (2020), and after (2021-2022) the COVID-19 lockdown, the trend of SR, and the factors associated. Three standardized questions from the \"Columbia-Suicide Severity Rating Scale\" (C-SSRS) were routinely applied as screening for suicide risk to all PWH attending their clinical visits during 2018-2022. We estimated suicidality risk and rate. We compared sociodemographic characteristics in those with and without SR. We evaluated the potential association of SR with the calendar year before, during, and after the COVID-19 lockdown using a mixed-effects logistic regression. A total of 2330 patients were seen during the study period; 2157 (93%) were evaluated for suicidality at least once, of those, 75 (3.5%) had SR. Those with SR compared with non-SR were more frequently women (20% vs 10%) and with a heterosexual HIV transmission route (29% vs 23%). SR rates per 1000 patients-day among those evaluated were 0.03 in 2018, 0.25 in 2019, 3.16 in 2020, 7.0 in 2021 and 11.98 in 2022. Throughout the model, independently of covariables, a significant increase in the OR of SR was observed in these years compared to 2018: 1.07 in 2019; 2.74 in 2021; and 4.82 in 2022, except in 2020, OR = 0.18.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilization of an Off-Site Patient Navigator to Facilitate HIV Pre-Exposure Prophylaxis Referrals in Patients with Sexually Transmitted Infections in the Emergency Department.","authors":"Ashley Lipps, Natalie Nielsen, Anne Dannemiller, Yesha Patel, Jose A Bazan, JaNelle Ricks, Susan L Koletar, Carlos Malvestutto","doi":"10.1007/s10461-024-04563-0","DOIUrl":"https://doi.org/10.1007/s10461-024-04563-0","url":null,"abstract":"<p><p>The emergency department (ED) is an important setting to identify people at increased risk of HIV infection who may benefit from HIV pre-exposure prophylaxis (PrEP). However, prescribing or referral for PrEP in the ED is not widespread. The purpose of this study is to evaluate the use of an off-site HIV PrEP patient navigator to facilitate PrEP access for patients who seek care for sexually transmitted infections (STIs) in the ED. Between January 1, 2023 and June 30, 2023, patients who tested positive for a bacterial STI in the ED were eligible for outreach by an off-site PrEP patient navigator. Interested patients were scheduled for telehealth appointments for PrEP. Demographic, clinical information and outcomes were obtained. During the study period, there were 160 patients eligible for PrEP outreach. Outreach was completed in 75 (47%) of patients, with 46/75 (61%) agreeable to scheduling a PrEP appointment. Of these 46 patients, median age was 30 years old [IQR 23, 35], 25 (54%) were male, 40 (87%) were Black/African American and 6 (13%) identified as men who have sex with men (MSM). Forty three of 46 interested patients (93%) scheduled an appointment and 35/46 (76%) completed an appointment. Thirteen of 35 (37%) patients who completed an appointment were prescribed PrEP, with 6/13 (46%) and 2/13 (15%) remaining on PrEP at 3 and 6 months, respectively. Use of an off-site patient navigator can facilitate referrals for HIV PrEP for patients who are diagnosed with bacterial STIs in the ED.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceptions of Molecular HIV Surveillance Among Men Who Have Sex with Men in the United States.","authors":"Marisol Valenzuela Lara, Travis H Sanchez, Juli M Bollinger, Gail Geller, Susan J Little, Jeremy Sugarman","doi":"10.1007/s10461-024-04557-y","DOIUrl":"https://doi.org/10.1007/s10461-024-04557-y","url":null,"abstract":"<p><p>Expanding HIV cluster detection using molecular HIV surveillance (MHS) raises ethical and social concerns, which may impede HIV outbreak detection and response as well as deter people living with HIV from seeking care. This underscores the need for effective communication strategies. We examined two methods for explaining MHS among men who have sex with men (MSM) living with HIV and at-risk without HIV in the United States. Participants recruited during the 2021 American Men's Internet Survey (AMIS) were randomized to view a brief video (N = 822) or text (N = 1701) explaining MHS. Respondents with high video engagement were less likely to be concerned about MHS. In the text group, discomfort with MHS decreased as awareness of different public health activities increased. Overall, information about MHS and increased awareness of it improved its acceptability. Effective communication is an essential prerequisite for meaningfully engaging stakeholders regarding MHS implementation in HIV prevention and control efforts.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study.","authors":"Erin E Cooney, Meg Stevenson, Rodrigo A Aguayo-Romero, Genesis Valera, Tonia C Poteat, Kenneth H Mayer, Chris Beyrer, Keri N Althoff, Asa E Radix, Andrew J Wawrzyniak, Christopher M Cannon, Jason S Schneider, Carolyn A Brown, Vani Vannappagari, Leigh Ragone, Annemiek de Ruiter, Sari L Reisner, Andrea L Wirtz","doi":"10.1007/s10461-024-04561-2","DOIUrl":"https://doi.org/10.1007/s10461-024-04561-2","url":null,"abstract":"<p><p>HIV incidence among transgender women remains high and disproportionately impacts young, Black, and Latina transgender women. Data on preferred PrEP modalities among this population are limited. Participants in The LITE Cohort completed a survey module on PrEP modality preferences during 24-month study visits. We summarized ranked preferences based on an exhaustive set of 10 head-to-head comparisons of 5 PrEP modalities (pill, injection, implantable device, topical gel, and intravenous antibodies) and conducted in-depth interviews to contextualize findings. Between 2020 and 2022, 789 participants completed the PrEP modality survey module. The most preferred PrEP modality was the implant (ranked first among 45% of respondents), followed by pill (21%), injection (19%), gel (10%), and intravenous antibodies (4%). The implant ranked highest among Latina transgender women (36%), young adult transgender women (ages 18-24 years; 41%), those living in the South (47%), and those with PrEP indication(s) (45%), while injection was the top-ranked modality among Black transgender women (30%). Qualitative analysis of in-depth interviews (n = 45) revealed that PrEP modality preferences were individualized, context-dependent, considered gender-related factors (e.g. gender-affirming hormone injections), and informed by prior healthcare experiences, personal values, and anticipated modality-specific facilitators and barriers. Our findings suggest high interest in long-acting PrEP options, including implants and injections, and daily pills among transgender women.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era.","authors":"Jimmy Ma, Joseph A C Delaney, Stephanie A Ruderman, Robin M Nance, Andrew W Hahn, Lydia N Drumright, Bridget M Whitney, Rob J Fredericksen, L Sarah Mixson, Joseph O Merrill, Steven A Safren, Kenneth H Mayer, Conall O'Cleirigh, Sonia Napravnik, Geetanjali Chander, Richard D Moore, Katerina A Christopoulos, Amanda L Willig, Laura Bamford, Allison Webel, Mary E McCaul, Edward R Cachay, Jeffrey M Jacobson, Michael S Saag, Mari M Kitahata, Heidi M Crane, Emily C Williams","doi":"10.1007/s10461-024-04566-x","DOIUrl":"https://doi.org/10.1007/s10461-024-04566-x","url":null,"abstract":"","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychometric Validation of the East Africa Alcohol Expectancy Scale (AFEXS) for Youth Living with HIV in Southwestern Uganda.","authors":"Massy Mutumba, Rachel Brathwaite, Sylvia Nannono, Phionah Namatovu, Anita Kabarambi, Lindsey M Filiatreau, Fred M Ssewamala","doi":"10.1007/s10461-024-04559-w","DOIUrl":"https://doi.org/10.1007/s10461-024-04559-w","url":null,"abstract":"<p><p>Reliable and valid assessment tools are crucial for measuring alcohol use expectancies (AUE) among youth living with HIV (YLHIV). In this paper, we assess the psychometric properties of the original 17-item East Africa Alcohol Expectancy Scale (AFEXS) among Ugandan YLHIV-a scale developed and validated by Woolf-King et al. for use among Uganda adults living with HIV. Specifically, we applied the measure to a sample of 100 Ugandan YLHIV enrolled in a substance use intervention. To analyze the psychometric properties, we conducted exploratory factor analysis (EFA), confirmatory factor analysis (CFA), and convergent validity analyses. The resulting 15-item youth AFEXS scale differed from the 11-item adult version. The 15-item Youth AFEXS demonstrated high internal consistency (α = 0.85), aligning with theoretical expectations of a three-factor structure related to sexual expectancies (7 items; α = 0.89), negative expectancies (4 items; α = 0.72), and release of inhibition expectancies (4 items; α = 0.77). The global scale and sub-scales demonstrated satisfactory convergent validity through positive correlations measures of frequency of alcohol consumption in the past 12 months: global AFEXS (r = 0.617; p = 0.000), sexual expectancies (r = 0.583; p = 0.000), negative expectancies (r = 0.618; p = 0.000), and release expectancies (r = 0.596; p = 0.000). The study confirms the youth AFEXS as a reliable and valid tool for assessing AUE among Ugandan YLHIV.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HIV Support Group Care Utilization and its Effect on Treatment Outcome Among HIV Patients on Antiretroviral Therapy: Evidence from Ethiopia Population-Based HIV Impact Assessment.","authors":"Tegene Atamenta Kitaw, Ribka Nigatu Haile","doi":"10.1007/s10461-024-04562-1","DOIUrl":"https://doi.org/10.1007/s10461-024-04562-1","url":null,"abstract":"<p><p>In the realm of HIV care, support groups play a pivotal role by bringing together individuals living with HIV to share experiences and receive guidance from healthcare professionals. These groups are renowned for their substantial benefits, including improving emotional well-being, enhancing treatment adherence, and fostering a strong sense of community. However, despite these advantages, there is a notable gap in Ethiopia regarding concrete evidence of their impact on key treatment outcomes. This study aims to bridge this gap by exploring how support group care influences viral suppression rates among HIV patients. The study was conducted among 259 HIV-positive individuals on ART using the EPHIA survey, employing a two-stage, stratified sampling design across urban areas in nine regions and two city administrations. Data analysis was performed using STATA version 17, and multicollinearity was assessed (VIF = 1.07). A multivariate logistic regression model was fitted, with a p-value of ≤ 0.05 considered statistically significant. Results showed that 25.12% of participants utilized HIV support groups. Those who participated in support groups were 3.14 times more likely to achieve viral load suppression compared to non-participants (AOR = 3.14, 95% CI: 1.35-6.30). This study highlights that HIV support groups significantly boost viral suppression rates, underscoring the importance of integrating these groups into standard treatment protocols. These findings underline the need for continued research to assess long-term outcomes and further optimize the effectiveness of support group care in enhancing HIV treatment outcomes.</p>","PeriodicalId":7543,"journal":{"name":"AIDS and Behavior","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}